Dengxu Tan

Xi'an, 710032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

LRRC8D Suppresses Prostate Cancer Growth and Enhances Platinum Sensitivity via Modulation of CAV-1/STAT3 Signaling.

LRRC8D Suppresses Prostate Cancer Growth and Enhances Platinum Sensitivity via Modulation of CAV-1/STAT3 Signaling.

Journal: Membranes

Published: April 13, 2026

Correction: Zhang et al. The Application of Heptamethine Cyanine Dye DZ-1 and Indocyanine Green for Imaging and Targeting in Xenograft Models of Hepatocellular Carcinoma. Int. J. Mol. Sci. 2017, 18, 1332.

Correction: Zhang et al. The Application of Heptamethine Cyanine Dye DZ-1 and Indocyanine Green for Imaging and Targeting in Xenograft Models of Hepatocellular Carcinoma. Int. J. Mol. Sci. 2017, 18, 1332.

Journal: International journal of molecular sciences

Published: October 29, 2025

Resveratrol amplifies the anti-tumor effect of α-PD-1 by altering the intestinal microbiome and PGD2 content.

Resveratrol amplifies the anti-tumor effect of α-PD-1 by altering the intestinal microbiome and PGD2 content.

Journal: Gut microbes

Published: January 06, 2025

FXYD5 regulates gastric cancer cell metastasis and drug resistance by EMT modulation.

FXYD5 regulates gastric cancer cell metastasis and drug resistance by EMT modulation.

Journal: Cancer gene therapy

Published: October 30, 2024

Engineered Bacteria Manipulate Cysteine Metabolism to Boost Ferroptosis-Based Pancreatic Ductal Adenocarcinoma Therapy.

Engineered Bacteria Manipulate Cysteine Metabolism to Boost Ferroptosis-Based Pancreatic Ductal Adenocarcinoma Therapy.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: August 30, 2024

Small Mitochondria-Targeting Fluorophore with Multifunctional Therapeutic Activities against Prostate Cancer via the HIF1α/OATPs Pathway.

Small Mitochondria-Targeting Fluorophore with Multifunctional Therapeutic Activities against Prostate Cancer via the HIF1α/OATPs Pathway.

Journal: Molecular pharmaceutics

Published: November 13, 2023

Establishment of organoid models for pancreatic ductal adenocarcinoma and screening of individualized therapy strategy.

Establishment of organoid models for pancreatic ductal adenocarcinoma and screening of individualized therapy strategy.

Journal: Animal models and experimental medicine

Published: June 01, 2023

The Application of [68Ga]-Labeled FAPI-04 PET/CT for Targeting and Early Detection of Pancreatic Carcinoma in Patient-Derived Orthotopic Xenograft Models.

The Application of [68Ga]-Labeled FAPI-04 PET/CT for Targeting and Early Detection of Pancreatic Carcinoma in Patient-Derived Orthotopic Xenograft Models.

Journal: Contrast media & molecular imaging

Published: May 07, 2022

Lipocalin 2 may be a key factor regulating the chemosensitivity of pancreatic cancer to gemcitabine.

Lipocalin 2 may be a key factor regulating the chemosensitivity of pancreatic cancer to gemcitabine.

Journal: Biochemistry and biophysics reports

Published: December 03, 2021

Mediated Imaging and Improved Targeting of Farnesylthiosalicylic Acid Delivery for Pancreatic Cancer via Conjugation with Near-Infrared Fluorescence Heptamethine Carbocyanine Dye.

Mediated Imaging and Improved Targeting of Farnesylthiosalicylic Acid Delivery for Pancreatic Cancer via Conjugation with Near-Infrared Fluorescence Heptamethine Carbocyanine Dye.

Journal: ACS applied bio materials

Published: February 17, 2020

Development of patient-derived xenograft models of prostate cancer for maintaining tumor heterogeneity.

Development of patient-derived xenograft models of prostate cancer for maintaining tumor heterogeneity.

Journal: Translational andrology and urology

Published: December 07, 2019

Establishment and characterization of patient-derived xenografts for hormone-naïve and castrate-resistant prostate cancers to improve treatment modality evaluation.

Establishment and characterization of patient-derived xenografts for hormone-naïve and castrate-resistant prostate cancers to improve treatment modality evaluation.

Journal: Aging

Published: November 03, 2019

Showing 1-12 of 16

Last Updated: 09/26/2026